GB/T 16886.18-2022
Biological evaluation of medical devices—Part 18: Chemical characterization of medical device materials within a risk management process (English Version)

Standard No.
GB/T 16886.18-2022
Language
Chinese, Available in English version
Release Date
2022
Published By
General Administration of Quality Supervision, Inspection and Quarantine of the People‘s Republic of China
Latest
GB/T 16886.18-2022
Replace
GB/T 16886.18-2011
Scope
This document specifies the qualitative and quantitative (if necessary) framework for medical device components, the identification of biological hazards (sources) of material components and their biological risk assessment and control through progressive chemical characterization. This document is applicable to one or more of the following: --- the characterization of its manufacturing materials (medical device construction); --- the characterization of the manufacturing materials by qualitative and quantitative material chemical composition (material composition); --- Characterization of chemical substances introduced during the manufacturing process of medical devices (such as release agents, process contaminants, sterilization residues); --- the possibility of releasing chemical substances from medical devices or their manufacturing materials under clinical use conditions Estimation (using laboratory extraction conditions) (extractables); version——determination of chemical substances released by medical devices under their clinical use conditions (leachables). This document is also applicable to the chemical characterization (e.g. qualitative and/or quantitative) of degradation products. ISO 10993 9, ISO 10993 13, quasi-ISO 10993 14 and ISO 10993 15 cover other aspects of degradation evaluation. The national standard GB/T(Z) 16886 (all parts) applies to materials or medical devices that come into direct or indirect contact with the human body (see ISO10993 1 "Classification according to the nature of human body contact"). This document is intended to support biological evaluation for material suppliers and medical device manufacturers.

GB/T 16886.18-2022 Referenced Document

  • ISO 10993-1 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
  • ISO 14971 Medical devices - Application of risk management to medical devices

GB/T 16886.18-2022 history

  • 2022 GB/T 16886.18-2022 Biological evaluation of medical devices—Part 18: Chemical characterization of medical device materials within a risk management process
  • 2011 GB/T 16886.18-2011 Biological evaluation of medical devices.Part 18: Chemical characterization of materials
Biological evaluation of medical devices—Part 18: Chemical characterization of medical device materials within a risk management process

GB/T 16886.18-2022 -All Parts

GB/T 16886.1-2022 Biological evaluation of medical devices—Part 1: Evaluation and testing within a risk management process GB/T 16886.10-2017 Biological evaluation of medical devices—Part 10: Tests for irritation and skin sensitization GB/T 16886.11-2021 Biological evaluation of medical devices—Part 11: Tests for systemic toxicity GB/T 16886.12-2023 Biological Evaluation of Medical Devices Part 12: Sample Preparation and Reference Materials GB/T 16886.13-2017 Biological evaluation of medical devices—Part 13: Identification and quantification of degradation products from polymeric medical devices GB/T 16886.14-2003 Biological evaluation of medical devices--Part 14: Identification and quantification of degradation products from ceramics GB/T 16886.15-2022 Biological evaluation of medical devices—Part 15: Identification and quantification of degradation products from metals and alloys GB/T 16886.16-2021 Biological evaluation of medical devices—Part 16: Toxicokinetic study design for degradation products and leachables GB/T 16886.17-2005 Biological evaluation of medical devices.Part 17:Establishment of allowable limits for leachable substances GB/T 16886.18-2022 Biological evaluation of medical devices—Part 18: Chemical characterization of medical device materials within a risk management process GB/T 16886.19-2022 Biological evaluation of medical devices—Part 19: Physico-chemical, morphological and topographical characterization of materials GB/T 16886.2-2011 Biological evaluation of medical devices.Part 2: Animal welfare requirements GB/T 16886.20-2015 Biological evaluation of medical devices.Part 20:Principles and methods for immunotoxicology testing of medical devices GB/T 16886.23-2023 Biological Evaluation of Medical Devices Part 23: Stimulation Test GB/T 16886.3-2019 Biological evaluation of medical devices—Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity GB/T 16886.4-2022 Biological evaluation of medical devices—Part 4: Selection of tests for interactions with blood GB/T 16886.5-2017 Biological Evaluation of Medical Devices Part 5: In Vitro Cytotoxicity Tests GB/T 16886.6-2022 Biological evaluation of medical devices—Part 6:Tests for local effects after implantation GB/T 16886.7-2015 Biological evaluation of medical devices—Part 7: Ethylene oxide sterilization residuals GB/T 16886.9-2022 Biological Evaluation of Medical Devices Part 9: Qualitative and Quantitative Framework for Potential Degradation Products



Copyright ©2024 All Rights Reserved